Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of AST-001 in AKR1C3-high advanced pancreatic cancer
CTR20220935Phase 2Active
- Sponsor
- Accendatech
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Threonine in pancreatic cancer (PC), sponsored by Accendatech. Started Apr 2022; status: active.
02
Drugs
Threonine
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on CTR20220935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220935.